INTERNATIONAL PATENT: CURIUM US LLC FILES APPLICATION FOR "RADIOPHARMACEUTICAL COMPOSITIONS FOR ACTINIUM IN TARGETED RADIONUCLIDE THERAPY"

GENEVA, Nov. 19 -- CURIUM US LLC (111 Westport Plaza, Suite 800St. Louis, Missouri 63146) filed a patent application (PCT/US2025/028745) for "RADIOPHARMACEUTICAL COMPOSITIONS FOR ACTINIUM IN TARGETED RADIONUCLIDE THERAPY" on May 09, 2025. With publication no. WO/2025/235951, the details related to the patent application was published on Nov 13, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): JALOMAKI, Jarno (c/o CURIUM US LLC111 Westport Plaza, Suite 800St. Louis, Missouri 63146), SEPPANEN, Salla (c/o CURIUM US LLC111 Westport Plaza, Suite 800St. Louis, Missouri 63146), PARVIAINEN, Riku (c/o...